Sunday, February 09, 2014

Ashlee Vance on Illumina and the $1,000 genome sequencing

There was a really interesting feature from a recent issue of Businessweek with Ashlee Vance writing "Illumina's new low-cost genome machine will change health care forever."

It's fascinating from the perspective of people gaining affordable access to information about the genetic traits that may eventually kill them and with it being in the medical realm, brings to mind other pieces I've linked to in "Has Carl June Found a Key to Fighting Cancer?" by Jason Fagone for Philadelphia Magazine, "Craig Venter’s Bugs Might Save the World" by Wil Hylton for the New York Times Magazine and "Patient Zero" by Tom Junod and Mark Warren for Esquire.